Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Join | Sign in
Home>Products

  Featured Products

Product News
High ThroughputPARP in vivo Pharmacodynamic Assay
Monday, February 23, 2015
AMSBIO has introduced a unique High Throughput PARP in vivo Pharmacodynamic Assay that can be used to monitor the efficacy of poly-ADP-ribose polymerase (PARP) inhibitors on PAR formation in vivo; and to measure drug action on PARP in both in vivo and in vitro settings.

AstraZeneca Licenses Labguru Research and Lab Management Software
Thursday, February 19, 2015
Technology solution to streamline collaborations between lab staff and across institutions.

Cellular Dynamics’ iCell Hepatocytes Enable Malaria-in-a-Dish Studies
Thursday, February 12, 2015
Study published in February issue of Stem Cell Reports describes successful use of iPSC-derived cells for development of anti-malarial drug testing.

CAP® Derived Recombinant C1 Inhibitor Matches Berinert® in Animal Study
Tuesday, February 03, 2015
A safer and more economic therapy for acute and prophylactic HAE indications.

Hepregen Launches First Dog HepatoPac® Assay Kit
Friday, January 30, 2015
Application-directed kit complements human, rat and monkey counterparts.

Product NewsProduct News
Scientific News
3-D Engineered Bone Marrow Makes Functioning Platelets
Scalable model supports patient-specific treatments, advanced study of blood disorders.
Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
A novel microdevice capable of detecting 42 unique immune effector proteins has been developed.
Mini Synthetic Organism Instead Of Test Animals
Using a compact multi-organ chip, and those of three separate microcircuits, researchers can study the regeneration of certain kidney cells.
Novel Organoid Matrix Enables Long-Term Culture of Human Hepatocytes
Organoid growth matrix to enable long-term culture of genome-stable bipotent stem cells from adult human liver.
First Contracting Human Muscle Grown in Laboratory
Researchers at Duke University report the first lab-grown, contracting human muscle, which could revolutionize drug discovery and personalized medicine.
Antriabio Announces Completion Of PK/PD Studies Of AB101
AB101 positioned to be the first once-weekly basal insulin for diabetes patients.
Anti-Diabetic Drug Springs New Hope for Tuberculosis Patients
Drug for treating diabetes can double up as adjunct treatment for tuberculosis.
A Poisonous Cure
Toxic fungi may hold the secrets to tackling deadly diseases.
Antibiotic Resistance Threatens Future of Modern Medicine
Overuse and misuse of antibiotics, one of the key contributors to antimicrobial resistance (AMR).
Bacterial Toxin Targets Discovered
Understanding how bacterial toxins target human cells is set to have major implications for the development of novel drugs.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters